Wuxi Bio (02269) spent 659,800 Hong Kong dollars on September 20 to repurchase 54,000 shares.
WuXi Biologics (02269) disclosed in an announcement that on September 20, 2024, the company spent HK$659,800 to buy back...
WUXI BIO (02269) announced that on September 20, 2024, the company repurchased 54,000 shares for a total of 659,800 Hong Kong dollars, at a repurchase price of 12.20-12.22 Hong Kong dollars per share.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
